ADVFN Logo ADVFN
市場データ
ニュース
投資ツール
市場
発見

Hot Features

Follow Feed

フォローフィードコミュニティでトレーダーや投資家とつながりましょう.

ライブオプションフロー

包括的なオプション データを調査し、オプション フローで高度なフィルターを使用します.

モニター

ターミナル モニターで株式と資産のウォッチリストを整理および監視します
サインイン Premium Iconプレミアム Help Menu
Bitcoin
63,083.85
-2.73%
S&P 500
5,631.22
0.28%
Dow Jones
40,211.72
0.53%
US Dollar vs Yen
158.4455
0.19%
Brent Oil
83.665
-0.80%
Registration Strip Icon for discussion 登録して、同じ考えを持つ投資家と議論するためのアクティブなフォーラムで相互作用するためのアクティブなフォーラムに参加してください。
登録
  1. ホーム
  2. 投資
  3. 株式
  4. アメリカ
  5. NASDAQ
  6. Vanda Pharmaceuticals Inc (VNDA)

  7. Vanda Pharmaceuticals Inc (VNDA) ニュース

VNDA

Vanda Pharmaceuticals (VNDA)

Vanda Pharmaceuticals Inc
から:
次の項目別のソート:
 Showing the most relevant articles for your search:NASDAQ:VNDA
日付受信時刻ニュースソース見出しコード企業名
2020/06/1206 : 17Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:VNDAVanda Pharmaceuticals Inc
2020/06/1205 : 07Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:VNDAVanda Pharmaceuticals Inc
2020/06/0305 : 14Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:VNDAVanda Pharmaceuticals Inc
2020/05/3005 : 12Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:VNDAVanda Pharmaceuticals Inc
2020/05/2620 : 14Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:VNDAVanda Pharmaceuticals Inc
2020/05/2620 : 12Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:VNDAVanda Pharmaceuticals Inc
2020/05/2620 : 00PR Newswire (US)Vanda Pharmaceuticals Announces Virtual 2020 Stockholder MeetingNASDAQ:VNDAVanda Pharmaceuticals Inc
2020/05/2106 : 20PR Newswire (US)Vanda Pharmaceuticals Wins Motion To Dismiss False Claims Act LawsuitNASDAQ:VNDAVanda Pharmaceuticals Inc
2020/05/2023 : 45PR Newswire (US)Vanda Pharmaceuticals CEO's Proposal on Clinical Trial Data Sharing, COVID-19 and RemdesivirNASDAQ:VNDAVanda Pharmaceuticals Inc
2020/05/1320 : 44Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:VNDAVanda Pharmaceuticals Inc
2020/05/1320 : 00PR Newswire (US)Vanda Pharmaceuticals Announces Agreement with FDA on Resubmission of the Application for HETLIOZ® for the Treatment of Pati...NASDAQ:VNDAVanda Pharmaceuticals Inc
2020/05/0720 : 02Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:VNDAVanda Pharmaceuticals Inc
2020/05/0705 : 18Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:VNDAVanda Pharmaceuticals Inc
2020/05/0705 : 01PR Newswire (US)Vanda Pharmaceuticals Reports First Quarter 2020 Financial ResultsNASDAQ:VNDAVanda Pharmaceuticals Inc
2020/04/3005 : 05PR Newswire (US)Vanda Pharmaceuticals to Announce First Quarter 2020 Financial Results on May 6, 2020NASDAQ:VNDAVanda Pharmaceuticals Inc
2020/04/2505 : 43Edgar (US Regulatory)Confidential Treatment Order (ct Order)NASDAQ:VNDAVanda Pharmaceuticals Inc
2020/04/2305 : 07Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:VNDAVanda Pharmaceuticals Inc
2020/04/2305 : 06Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:VNDAVanda Pharmaceuticals Inc
2020/04/1605 : 15PR Newswire (US)Vanda Pharmaceuticals Announces Initiation of "CALYPSO" to Study the Role of Genetic Variation in COVID-19 Infections in Coll...NASDAQ:VNDAVanda Pharmaceuticals Inc
2020/04/1605 : 05PR Newswire (US)Vanda Pharmaceuticals, Northwell Health Conduct ODYSSEY Trial In Patients With Severe COVID-19 PneumoniaNASDAQ:VNDAVanda Pharmaceuticals Inc
2020/04/0905 : 05PR Newswire (US)Vanda Pharmaceuticals Inc. And The University of Illinois at Chicago Announce Partnership To Identify Novel Antivirals Agains...NASDAQ:VNDAVanda Pharmaceuticals Inc
2020/04/0302 : 37PR Newswire (US)Vanda Pharmaceuticals Announces the Initiation of ODYSSEY, an FDA Approved Clinical Study of Tradipitant in Hospitalized Pati...NASDAQ:VNDAVanda Pharmaceuticals Inc
2020/03/2505 : 11Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:VNDAVanda Pharmaceuticals Inc
2020/03/1406 : 18Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:VNDAVanda Pharmaceuticals Inc
2020/03/0507 : 04Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:VNDAVanda Pharmaceuticals Inc
2020/03/0507 : 03Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:VNDAVanda Pharmaceuticals Inc
2020/03/0507 : 03Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:VNDAVanda Pharmaceuticals Inc
2020/03/0507 : 02Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:VNDAVanda Pharmaceuticals Inc
2020/03/0507 : 01Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:VNDAVanda Pharmaceuticals Inc
2020/03/0406 : 32Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:VNDAVanda Pharmaceuticals Inc
 Showing the most relevant articles for your search:NASDAQ:VNDA

最近閲覧した銘柄

AMEX
XLF
Financial Select Sector
CCOM
US500
US 500
NYSE
MCD
McDonalds
COIN
SOLUSD
Solana
NASDAQ
GOOGL
Alphabet
SPI
SP500
S&P 500
USOTC
BNPQY
BNP Paribas (QX)
AMEX
SPY
SPDR S&P 500
USI
USTECH100
US Tech 100
FX
USDGBP
US Dollar vs Sterling
NASDAQ
QQQ
Invesco QQQ Trust Series 1
FX
USDJPY
US Dollar vs Yen
PM
XAUUSD
Gold vs US Dollar
NYSE
XOM
Exxon Mobil
CCOM
SILVER
SILVER
NASDAQ
NVDA
NVIDIA
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

日本
会社情報
ビジネス
人気
アプリを入手
App Store
Google Play

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

© 2024 ADVFN PLC - 全著作権所有